Antares Pharma reported $1.7M in Ordinary Share Capital for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Adma Biologics ADMA:US $ 0.02M 0M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Ani Pharmaceuticals ANIP:US $ 0M 0M
Atrion ATRI:US 342K 0
Becton, Dickinson and BDX:US $ 365M 0M
Cara Therapeutics CARA:US $ 53K 0
Cerus CERS:US $ 0.18M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Horizon Pharma HZNP:US $ 0.02M 0M
Orasure Technologies OSUR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 0.05M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Sientra SIEN:US $ 0.62M 0M
Staar Surgical STAA:US $ 0.48M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Teva Pharmaceutical Industries TEVA:US $ 57M 0M